-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, with the expansion of the pharmaceutical consumption scene, new pharmaceutical retailing is gradually becoming the new darling of the industry, more and more industry giants began to accelerate the layout of pharmaceutical retailing.
, according to tian-eye inspection information, on October 19, Jiangsu Suning University Pharmacy Co., Ltd. was established, the legal representative is Zhai Zhenyu, registered capital of 10 million.
distribution scope includes drug retailing, drug Internet information services, third-class medical device operations, health food sales, food Internet sales (sales of prepackaged food) and so on.
this, industry insiders believe that this means that Suning Tesco already has the legal qualifications of the pharmaceutical retail industry, is about to enter the pharmaceutical retail industry.
fact, Suning Tesco has been actively involved in the field of medicine and health in recent years.
As early as 2016, Suning Tesco obtained the "Internet Drug Information Service Qualification Certificate", and in that year launched Suning Tesco Pharmaceutical Museum, began from offline home appliance chain transformation integrated e-commerce, involved in pharmaceutical e-commerce third-party platform.
April 2020, Suning Tesco and Shanghai Fosun Group reached a strategic partnership, will be in the pharmaceutical, consumer health care, home customer service and other fields, around the online e-commerce channels and offline stores in-depth co-creation.
June 4, Suning Tesco reached a strategic agreement with Fish Leap Medical Group, which will carry out in-depth construction of pharmaceutical O2O in the future, and strengthen cooperation in logistics storage services, health and other fields.
August, suning Tesco said in response to investor questions that it was considering promoting cooperation with third-party Internet hospitals to open a medical consultation business through Suning Tesco's POP platform, while integrating the supply chain of pharmacies across the country and providing online re-diagnosis and prescriptions for Suning Tesco users to meet the demand for medicines.
fact, in addition to Suning, in recent years petrochemical, physical beauty, Watson and other chain giants are actively increasing the code into the pharmaceutical industry.
as early as last June, Sinopec Group's easyJet convenience store has applied for a "drug license", intended to enter the pharmaceutical retail industry.
this year, Hainan One Heart Ton and Sinopec reached a strategic cooperation, the first cooperative pharmacy has been stationed in Sinopec Binhai Avenue gas station.
addition, in June this year, the enterprise inspection data show that Shenzhen Box Horse Network Technology Co., Ltd. business scope has also added a third category of medical devices wholesale and retail.
so many enterprises pile up layout pharmaceutical retail industry, is undoubtedly optimistic about its future market development.
data show that in 2019, the overall sales of retail pharmacies nationwide reached 400.8 billion yuan, although the year-on-year growth rate fell to a low level of 4.3%.
drug market will remain at a normal growth rate of 7.5 per cent for a long time to come.
in the pharmaceutical industry experienced a major reshuffle of the background, this market growth rate is very considerable.
, the entry of various capitals is undoubtedly a broad market opportunity for the future of the large health industry.
but for now, the pharmaceutical retail industry is still in the race.
against this background, relevant enterprises and pharmacies need to fully examine the huge impact of drug sales channel changes, and continuously improve pharmaceutical services, after all, these changes for the pharmaceutical industry is both a challenge and an opportunity.